Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Experimental:Conventional treatment and Shenfu injection
Sponsors
Peking University Third Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Confirmed and suspected cases of pneumonia from novel coronavirus infection; 2. Meet the diagnostic criteria for community - acquired pneumonia; 3. Clinical classification is "heavy" or "critical"; 4. Aged 18 to 75 years; 5. Obtain informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnancy or lactating women; 2. People with allergies or allergies to Shenfu injection and its components; 3. Severe basic diseases that affect survival, including: uncontrolled malignant tumors with multiple metastases that cannot be removed, hematological diseases, cachexia, active bleeding, severe malnutrition, HIV, etc.; 4. Obstructive pneumonia caused by lung tumors, severe pulmonary interstitial fibrosis, alveolar proteinosis, allergic reaction alveolitis; 5. Previous immunosuppressive agents within 6 months before study entry or recipients of a solid-organ or bone marrow transplant; 6. Extracorporeal life support (ECMO, ECCO2R, RRT); 7. Expected to die within 48 hours; 8. Patients who are considered by the investigator to be unsuitable subjects for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pneumonia severity index (PSI);Incidence of new organ dysfunction; | — |
Secondary
| Measure | Time frame |
|---|---|
| 28-day prognosis;SOFA;Mechanical ventilation time;Length of stay in ICU ;Total hospital expenses;Dosage of vasoactive drugs; | — |
Countries
China
Contacts
Public ContactMa Penglin
Peking University Third Hospital
Outcome results
None listed